This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: C4 Therepeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Stephan Roever
Introduction
Stephan Roever is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific proteins involved in cellular processes.
Latest Patents
Roever holds a patent for spirocyclic compounds. This invention provides compounds that bind to the E3 ligase protein cereblon (CRBN), which is widely expressed in various cells. The compounds are intended for the treatment of abnormal cellular proliferation. Additionally, they may serve as synthetic intermediates in the synthesis of bifunctional compounds used for targeted protein degradation.
Career Highlights
Throughout his career, Roever has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with C4 Therapeutics, Inc. and F. Hoffmann-La Roche AG. His work in these organizations has contributed to advancements in drug development and therapeutic strategies.
Collaborations
Roever has collaborated with several professionals in his field, including Christopher G. Nasveschuk and Fabian Dey. These collaborations have likely enhanced his research and innovation efforts.
Conclusion
Stephan Roever's work in developing spirocyclic compounds showcases his commitment to advancing medical science. His contributions are significant in the ongoing fight against diseases related to abnormal cellular proliferation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile